$1.12 Billion is the total value of Rhenman & Partners Asset Management AB's 82 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HAL | Exit | HALLIBURTON CO | $0 | – | -8,299 | -100.0% | -0.01% | – |
NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -6,926 | -100.0% | -0.02% | – |
WFC | Exit | WELLS FARGO CO NEW | $0 | – | -5,272 | -100.0% | -0.02% | – |
BUD | Exit | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $0 | – | -2,806 | -100.0% | -0.02% | – |
PFE | Exit | PFIZER INC | $0 | – | -4,508 | -100.0% | -0.02% | – |
DIS | Exit | DISNEY WALT CO | $0 | – | -1,338 | -100.0% | -0.02% | – |
JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -1,723 | -100.0% | -0.02% | – |
JHG | Exit | JANUS HENDERSON GROUP PLC | $0 | – | -8,645 | -100.0% | -0.02% | – |
IBM | Exit | INTERNATIONAL BUSINESS MACHS | $0 | – | -1,587 | -100.0% | -0.02% | – |
XOM | Exit | EXXON MOBIL CORP | $0 | – | -5,388 | -100.0% | -0.03% | – |
MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -0.43% | – |
OMCL | Exit | OMNICELL INC | $0 | – | -60,000 | -100.0% | -0.46% | – |
AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -285,000 | -100.0% | -0.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-10-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
ALKERMES PLC | 40 | Q3 2023 | 3.3% |
LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR/A | 2023-11-13 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.